Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Bank of America Co. 

Core Laboratories N.V. diskutieren

Core Laboratories Inc.

WKN: A3EB9S / Symbol: CLB / Name: Core Laboratories / Aktie / Öl & Gas - Ausrüstung und Service / Mid Cap /

?
0,00 %

Core Laboratories (NYSE: CLB) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Ratings data for CLB provided by MarketBeat

Einschätzung Sell
Rendite (%) -17,18 %
Kursziel 19,27
Veränderung
Endet am 30.06.24

Core Laboratories Inc. (NYSE: CLB) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $21.00 price target on the stock, down previously from $22.00.
Ratings data for CLB provided by MarketBeat

Einschätzung Sell
Rendite (%) -33,95 %
Kursziel 15,02
Veränderung
Endet am 15.04.25

Core Laboratories Inc. (NYSE: CLB) had its price target lowered by analysts at Bank of America Co. from $17.00 to $16.00. They now have an "underperform" rating on the stock.
Ratings data for CLB provided by MarketBeat

Einschätzung Sell
Rendite (%) -52,80 %
Kursziel 13,76
Veränderung
Endet am 16.07.25

Core Laboratories Inc. (NYSE: CLB) had its price target lowered by analysts at Bank of America Co. from $16.00 to $15.00. They now have an "underperform" rating on the stock.
Ratings data for CLB provided by MarketBeat

Einschätzung Sell
Rendite (%) -20,69 %
Kursziel 12,86
Veränderung
Endet am 31.10.25

Core Laboratories Inc. (NYSE: CLB) had its price target lowered by analysts at Citigroup Inc. from $15.00 to $14.00. They now have a "sell" rating on the stock.
Ratings data for CLB provided by MarketBeat

Einschätzung Sell
Rendite (%) -4,38 %
Kursziel 14,28
Veränderung
Endet am 20.02.26

Core Laboratories Inc. (NYSE: CLB) had its price target raised by analysts at Citigroup Inc. from $14.00 to $15.00. They now have a "sell" rating on the stock.
Ratings data for CLB provided by MarketBeat

Core Laboratories (CLB) was downgraded by Wall Street Zen from "hold" to "sell".
Ratings data for CLB provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 18,22
Veränderung
Endet am 13.08.27

Core Laboratories (CLB) was upgraded by Johnson Rice from "hold" to "buy". They now have a $21.00 price target on the stock.
Ratings data for CLB provided by MarketBeat